Global Stomach Cancer Treatment Market Size & Outlook
Global stomach cancer treatment market, 2018-2030 (US$M)
Related Markets
Global stomach cancer treatment market highlights
- The global stomach cancer treatment market generated a revenue of USD 5,369.6 million in 2024 and is expected to reach USD 11,194.9 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 12.5% by 2030.
- In terms of segment, targeted therapy accounted for a revenue of USD 2,542.3 million in 2024.
- Immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 5,369.6 million |
| Market revenue in 2030 | USD 11,194.9 million |
| Growth rate | 12.5% (CAGR from 2025 to 2030) |
| Largest segment | Targeted therapy |
| Fastest growing segment | Immunotherapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standard Chemotherapy, Targeted Therapy, Immunotherapy |
Other key industry trends
- In terms of revenue, the North America accounted for 20.7% of the global stomach cancer treatment market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UAE is the fastest growing regional market and is projected to reach USD 28.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stomach Cancer Treatment Market Scope
Stomach Cancer Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Samsung Bioepis | View profile | 501-1000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbioepis.com |
| Celltrion Healthcare | View profile | 51-100 | Incheon, Inch'on-jikhalsi, South Korea, Asia | http://www.celltrionhealthcare.com/ |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global stomach cancer treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.
Targeted therapy was the largest segment with a revenue share of 47.35% in 2024. Horizon Databook has segmented the Global stomach cancer treatment market based on standard chemotherapy, targeted therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Stomach Cancer Treatment Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Standard Chemotherapy
- Targeted Therapy
- Immunotherapy
- Global Stomach Cancer Treatment Disease Indication Outlook (Revenue, USD Million, 2018-2030)
- Gastric cancer/Gastroesophageal Junction cancer
- Gastrointestinal Stromal Tumors
- Global Stomach Cancer Treatment Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Injectable
- Oral
- Global Stomach Cancer Treatment Drug Class Outlook (Revenue, USD Million, 2018-2030)
- HER2 Antagonists
- Others
- PD-1/PD-L1 Inhibitors
- VEGFR Antagonists
Reasons to subscribe to Global stomach cancer treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global stomach cancer treatment market databook
-
Our clientele includes a mix of stomach cancer treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global stomach cancer treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global stomach cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global stomach cancer treatment market size, by regions, 2018-2030 (US$M)
Top 10 countries: Stomach cancer treatment market size, 2024 (US$M)
Global stomach cancer treatment market share, by drug class, 2024 & 2030 (%, US$M)
Stomach cancer treatment market: Opportunity assessment by country
Global stomach cancer treatment market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
